GARDASIL® (Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine)

$156.75 per 0Milliliters

GARDASIL VIAL MERCK & CO. Approx. Price: $156.75 per 0Milliliters

Dosage

GARDASIL should be administered intramuscularly as 3 separate 0.5-mL doses according to the following schedule:

First dose: at elected date
Second dose: 2 months after the first dose
Third dose: 6 months after the first dose

All Labeled Uses: Prevention of Cervical Cancer due to Human Papilloma Virus, Prevention of Genital Warts, Prevention of Vaginal Cancer due to Human Papilloma Virus, Prevention of Vulvar Cancer due to Human Papilloma Virus

Pediatric
Warning: SAFETY AND EFFICACY NOT ESTABLISHED IN PEDIATRICS < 9 YEARS.

The Advisory Committee on Immunization Practices (ACIP) voted Thursday to recommend that a newly licensed vaccine designed to protect against human papillomavirus virus (HPV) be routinely given to girls when they are 11-12 years old. The ACIP recommendation also allows for vaccination of girls beginning at nine years old as well as vaccination of girls and women 13-26 years old. HPV is the leading cause of cervical cancer in women;June 29, 2006

HPV Vaccine Information For Young Women